X
XERS
Xeris Biopharma Holdings
6.50
+0.26+4.17%After Hours: 6.51 +0.01 +0.15%19:57 06/09 EDT
OPEN/PREV CLOSE6.25/6.24
TODAY RANGE6.25-6.54
VOL1.71M
MARKET CAP1.12B
52 WEEK RANGE4.300-10.08
AVG VOL (3M)1.62M
% TURNOVER0.99%
TURNOVER--
P/E (TTM)117.12
% RANGE4.65%
EPS(TTM)0.0555
P/E(FORWARD)65.00
P/B86.21
BVPS0.0754
DIVIDEND--
P/S3.702
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.08B
SHARES OUTSTANDING172.64M
NEXT EARNINGS08/05-08/10
FREE FLOAT166.83M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·17h ago
Should Xeris Biopharma’s Q1 Beat and Director Stock Moves Prompt a Fresh Look From XERS Investors?
Seeking Alpha·05/31 03:31
Xeris Looks Ridiculously Cheap If Growth Forecasts Are Even Halfway Right
Simply Wall St·05/18 02:20
What Xeris Biopharma Holdings (XERS)'s Profit Return and Higher 2026 Guidance Means For Shareholders
Simply Wall St·05/15 11:48
Shareholders Will Be Pleased With The Quality of Xeris Biopharma Holdings' (NASDAQ:XERS) Earnings
TipRanks·05/14 09:21
Xeris Pharmaceuticals (XERS) Receives a Buy from Barclays
Simply Wall St·05/10 22:21
A Look At Xeris Biopharma Holdings (XERS) Valuation After Its Profit Turnaround And Guidance Hike
Simply Wall St·05/09 13:56
Results: Xeris Biopharma Holdings, Inc. Confounded Analyst Expectations With A Surprise Profit
TipRanks·05/08 10:50
H.C. Wainwright Remains a Buy on Xeris Pharmaceuticals (XERS)
TipRanks·05/08 01:27
Xeris Pharmaceuticals Signals Profitable Growth Acceleration
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.